RP Masiello broke ground on a new biopharma manufacturing facility on Commerce Drive in Northbridge on Wednesday. The 40,000-square-foot project is expected to be completed in late 2024.
Watertown-based EyePoint Pharmaceuticals will design and construct a new manufacturing facility in Northbridge focused on development and commercialization of therapeutics for severe eye disorders.